Watchlist Price Alert

ImmunoPrecise Antibodies ... (IPA)

NASDAQ: IPA · Real-Time Price · USD

0.45

-0.01 (-1.64%)

At close: May 09, 2025, 3:43 PM

ImmunoPrecise Antibodies Balance Sheet Statement

Financials in CAD. Fiscal year is May - April.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017	Apr 30, 2016
Cash & Equivalents	3.46M	8.28M	29.96M	41.76M	2.61M	5.47M	1.81M	2.58M	340.88K
Short-Term Investments	n/a	n/a	n/a	n/a	104.00	n/a	n/a	n/a	214.14K
Long-Term Investments	n/a	115K	142K	111K	118.9K	90.4K	90.4K	n/a	n/a
Other Long-Term Assets	561K	86K	82K	79K	85.13K	67.45K	9.19M	n/a	n/a
Receivables	4.07M	3.88M	3.41M	3.63M	3.66M	1.95M	2.22M	469.49K	450.91K
Inventory	2.14M	2.06M	1.61M	1.2M	818.64K	2.12M	412.69K	58.5K	2.79K
Other Current Assets	414K	536K	n/a	491K	88K	n/a	n/a	61.15K	209.05K
Total Current Assets	11.49M	16.79M	37.47M	48.86M	7.7M	9.88M	4.78M	3.28M	1.22M
Property-Plant & Equipment	16.7M	10.72M	3.71M	4.08M	3.17M	1.64M	1.58M	644.58K	162.65K
Goodwill & Intangibles	31.24M	50.1M	52.09M	13.84M	16.19M	16.67M	8.93M	n/a	n/a
Total Long-Term Assets	48.5M	61.02M	56.02M	18.1M	19.56M	18.47M	19.79M	644.58K	162.65K
Total Assets	59.99M	77.81M	93.49M	66.96M	27.26M	28.35M	24.58M	3.93M	1.38M
Account Payables	4.07M	2.48M	3.92M	1.34M	1.35M	1.59M	2.03M	664.45K	100.81K
Deferred Revenue	n/a	977K	1.03M	1.11M	1.47M	724.69K	317.54K	172.47K	279.33K
Short-Term Debt	n/a	n/a	1.31M	n/a	2.12M	2.79M	187.81K	n/a	n/a
Other Current Liabilities	2.49M	2.32M	2.17M	1.94M	3.7M	2.78M	2.05M	n/a	284.71K
Total Current Liabilities	8.12M	5.92M	9.26M	6.07M	7.93M	7.2M	4.28M	836.91K	385.52K
Long-Term Debt	n/a	n/a	n/a	1.53M	503K	28.72K	3.59M	n/a	n/a
Other Long-Term Liabilities	5.83M	7.94M	8.48M	n/a	2.61M	2.97M	3.96M	n/a	n/a
Total Long-Term Liabilities	17.94M	14.09M	8.95M	3.96M	4.25M	3.07M	7.59M	n/a	86.63K
Total Liabilities	26.07M	20.01M	18.21M	10.04M	12.18M	10.28M	11.87M	836.91K	472.15K
Total Debt	13.68M	7.27M	2.55M	3.46M	4.51M	2.93M	3.82M	n/a	n/a
Common Stock	119.77M	117.47M	114.56M	80.1M	34.09M	32.7M	20.46M	7.46M	232.00
Retained Earnings	-100.27M	-73.09M	-46.53M	-29.82M	-22.48M	-17.48M	-9.74M	-4.57M	907.93K
Comprehensive Income	2.02M	2.63M	-2.48M	-687K	-300.22K	-228.06K	277.09K	-737.22K	-686.61K
Shareholders Equity	33.92M	57.8M	75.28M	56.92M	15.09M	18.07M	12.7M	3.09M	908.26K
Total Investments	n/a	115K	142K	111K	119K	90.4K	90.4K	n/a	214.14K